Altered Calcium Homeostasis and Ultrastructure in Motoneurons of Mice Caused by Passively Transferred Anti-motoneuronal IgG

Journal of Neuropathology and Experimental Neurology

Volumn 56, Issue 1, 1997, Pages 21-39

  Engelhardt, Jozsef I ^a,c   Siklos, Laszlo ^b,c   Appel, Stanley H ^c  

^a UNIVERSITY OF SZEGED   (Hungary)

^b INSTITUTE OF EXPERIMENTAL MEDICINE   (Hungary)

^c BAYLOR COLLEGE OF MEDICINE   (United States)

Author keywords

Calcium; Immunoglobulin G; Motoneurons; Ultrastructure

Indexed keywords

CALCIUM; CALCIUM CHANNEL BLOCKING AGENT; DILTIAZEM; DIZOCILPINE MALEATE; IMMUNOGLOBULIN G; N METHYL DEXTRO ASPARTIC ACID RECEPTOR; NEUROPROTECTIVE AGENT;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMAL; ARTICLE; BAGG ALBINO MOUSE; CATTLE; DISEASE MODEL; DRUG ANTAGONISM; DRUG EFFECT; ELECTRON MICROSCOPY; GOAT; HOMEOSTASIS; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MOTONEURON; MOTOR NEURON DISEASE; MOUSE; NERVE FIBER; PASSIVE IMMUNIZATION; PATHOLOGY; SPINAL CORD; SYNAPSE VESICLE; ULTRASTRUCTURE;

AMYOTROPHIC LATERAL SCLEROSIS; ANIMALS; AXONS; CALCIUM; CALCIUM CHANNEL BLOCKERS; CATTLE; DILTIAZEM; DISEASE MODELS, ANIMAL; DIZOCILPINE MALEATE; GOATS; HOMEOSTASIS; HUMANS; IMMUNIZATION, PASSIVE; IMMUNOGLOBULIN G; MALE; MICE; MICE, INBRED BALB C; MICROSCOPY, ELECTRON; MOTOR NEURON DISEASE; MOTOR NEURONS; NEUROPROTECTIVE AGENTS; RECEPTORS, N-METHYL-D-ASPARTATE; SPINAL CORD; SYNAPTIC VESICLES;

EID: 0030638138     PISSN: 00223069     EISSN: None     Source Type: Journal    
DOI: 10.1097/00005072-199701000-00003     Document Type: Article

References (35)

1. Engelhardt JI, Siklos L, Kömüves L, Smith RG, Appel SH. Antibodies to calcium channels from ALS patients passively transferred to mice selectively increase intracellular calcium and induce ultrastructural changes in motoneurons. Synapse 1995;20:185-99
2. Siklos L, Engelhardt J, Harati Y, Smith RG, Joo F, Appel SH. Ultrastructural evidence for altered calcium in motor nerve terminals in amyotrophic lateral sclerosis. Ann Neurol 1996;39:203-16
3. Alexianu ME, Ho BA, Mohamed HA, La Bella V, Smith RG, Appel SH. The role of calcium-binding proteins in selective motoneuron vulnerability in amyotrophic lateral sclerosis. Ann Neurol 1994;36: 846-58
4. 2+ currents in a motor neuron cell line. Ann Neurol 1995;37:102-9
5. Appel SH, Engelhardt JI, Garcia J, Stefani E. Immunoglobulins from animal models of motor neuron disease and from human amyotrophic lateral sclerosis patients passively transfer physiological abnormalities to the neuromuscular junction. Proc Natl Acad Sci USA 1991;88:647-51
6. Plaitakis A, Constantakakis E, Smith J. The neuroexcitotoxic amino acids glutamate and aspartate are altered in the spinal cord and brain in amyotrophic lateral sclerosis. Ann Neurol 1988;24:446-49
7. Rothstein JD, Tsai G, Kuncl RW, et al. Abnormal excitatory amino acid metabolism in amyotrophic lateral sclerosis. Ann Neurol 1990;28:18-25
8. Rothstein JD, Van Kammen M, Levey AI, et al. Selective loss of glial glutamate transporter (GLT-1) in amyotrophic lateral sclerosis. Ann Neurol 1995;38:73-84
9. Ince P, Stout N, Shaw P, Slade J. Hunziker W. Parvalbumin and Calbindin D-28K in human motor system and in motor neuron disease. Neuropathol Appl Neurobiol 1993;19:291-99
10. Somogyi P, Takagi H. A note on the use of picric acid-paraformaldehyde-glutaraldehyde fixative for correlated light and electron microscopic immunocytochemistry. Neuroscience 1982;7:1779-83
11. Anderson MJ, Cohen MV. Fluorescent staining of acetylcholine receptors in vertebrate skeletal muscles. J Physiol 1974;237:385-400
12. Engelhardt JI, Appel SH, Killian JM. Experimental autoimmune motoneuron disease. Ann Neurol 1989;26:368-76
13. Towbin H, Gordon J. Immunoblotting and dot immunobinding. Current status and outlook. J Immunol Meth 1984;72:313-40
14. Borgers M, De Brabander DM, van Reempts DJ, Awouters F, Jacob WA. Intranuclear microtubules in lung mast cells of guinea pigs in anaphylactic shock. Lab Invest 1977;37:1-8
15. Borgers M, Thone F, van Neuten JM. The subcellular distribution of calcium and the effects of calcium-antagonists as evaluated with a combined oxalate-pyroantimonate technique. Acta Histochem 1981;S24:327-32
16. Reynolds ES. The use of lead citrate at high pH as an electon-opaque stain in electron microscopy. J Cell Biol 1963;17:208-12
17. Bauer R. Electron spectroscopic imaging: An advanced technique for imaging and analysis in transmission electron microscopy. Methods Microbiol 1988;20:113-46
18. Lang B, Newsom-Davis J, Wray D, Vincent A. Autoimmune aetiology for myasthenic (Eaton-Lambert) syndrome. Lancet 1981;2: 224-26
19. Fukuoka T, Engel AG, Lang B, Newsom-Davis J, Vincent A. Lambert-Eaton myasthenic syndrome: II. Immunoelectron microscopy localization of IgG at the mouse motor end-plate. Ann Neurol 1987;22:200-211
20. Kim YJ, Neher E. IgG from patients with Lambert-Eaton syndrome blocks voltage dependent calcium channels. Science 1988;239:405-8
21. Garcia J, Engelhardt JI, Appel SH, Stefani E. Increased mepp frequency as an early sign of experimental immune-mediated motor neuron disease. Ann Neurol 1990;28:329-34
22. Graham LT Jr, Shank RR Werman R, Aprison MH. Distribution of some synaptic transmitter suspects in cat spinal cord: Glutamic acid, aspartic acid, gamma-aminobutyric acid, glycine, and glutamine. J Neurochem 1967;14:465-72
23. 3H]MK-801 binding sites in the normal human spinal cord. Brain Res 1991;539:164-68
24. Rothstein JD, Kuncl RW. Neuroprotective strategies in a model of chronic glutamate-mediated motor neuron toxicity. J Neurochem 1995;65(2):643-51
25. Gersdorff H, Matthews G. Inhibition of endocytosis by elevated internal calcium in synaptic terminal. Nature 1994;370:652-55
26. Gonatas NK, Stieber A, Mourelatos Z, et al. Fragmentation of the Golgi apparatus of motoneurons in amyotrophic lateral sclerosis. Am J Pathol 1992;140:731-37
27. Dal Canto MC, Gurney ME. Development of central nervous system pathology in a murine transgenic model of human amyotrophic lateral sclerosis. Am J Pathol 1994;145/6:1091-1132
28. Dal Canto MC, Gurney ME. Neuropathological changes in two lines of mice carrying a transgene for mutant human SOD: A model of familial amyotrophic lateral sclerosis (FALS). Brain Res 1995;676:25-40
29. Ikonomidou C, Qin QY, Labruyere J, Olney JW. Motor neuron degeneration induced by excitotoxin agonists has features in common with those seen in the SOD-1 transgenic mouse model of amyotrophic lateral sclerosis. J Neuropath Exp Neurol 1996;55/2:211-24
30. Saji M, Miura M. Coexistence of glutamate and choline acetyltransferase in a major subpopulation of laryngeal motoneurons of the rat. Neurosci Lett 1991;123:175-78
31. 2+ channels at perisynaptic glial cells of the frog neuromuscular junction. J Neurosci 199;6:16:148-58
32. Smith RG, Hamilton S, Hofmann F, et al. Serum antibodies to L-type calcium channels in patients with amyotrophic lateral sclerosis. N Engl J Med 1992;327:1721-28
33. 1 subunit. Ann Neurol 1994;35:164-71
34. Llinas R, Sugimori M, Cherksey BD, et al. IgG from amyotrophic lateral sclerosis patients increased current through P-type calcium channels in mammalian cerebellar Purkinje cells and isolated channel protein in lipid bilayers. Proc Natl Acad Sci USA 1993;90: 11743-47
35. Brock TO, McIlwain DL. Relative postmortem stability of spinal motoneuronal proteins detectable by two-dimensional electrophoresis. Neurochem Pathol 1985;3(1):1-14